References
- Maack T, Hyung Park C, Camargo M JF. Renal filtration, transport and metabolism of proteins. The kidney: physiology and pathophysiology 2nd ed., D W Seldin, G Giebish. New York Raven Press. 1992; 3005–38
- Bianchi C, Donadio C, Tramonti G, Auner I, Lorusso P, Deleide G, et al. High and preferential accumulation in the kidney of anionic and cationic small proteins. Contrib Nephrol 1990; 83: 39–46
- Johansson B G, Ravnskov U. The serum level and urinary excretion of a a2-microglobulin, β2-micro-globulin and lysozyme in renal disease. Scand J Urol Nephrol 1972; 6: 249–56
- Sturfelt G, Truedsson L, Thysell H, Björk S. Serum level of complement factor D in systemic lupus erythematosus—an indicator of glomerular filtration rate. Acta Med Scand 1984; 216: 171–7
- Grubb A, Simonsen O, Sturfelt G, Truedsson L, Thysell H. Serum concentration of cystatin C, factor D and β2-microglobulin as a measure of glomerular filtration rate. Acta Med Scand 1985; 218: 499–503
- Kusano E, Suzuki M, Asano Y, Itoh Y, Takagi K, Kawai T. Human αl-microglobulin and its relationship to renal function. Nephron 1985; 41: 320–4
- Acchiardo S, Kraus A P, Jennings B R. β2-Microglobulin levels in patients with renal insufficiency. Am J Kidney Dis 1989; 13: 70–4
- Kyhse-Andersen J, Schmidt C, Nordin G, Anderson B, Nilsson-Ehle P, Lindstrom V, et al. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 1994; 40: 1921–6
- Newman D J, Thakkar H, Edwards R G, Wilkie M, White T, Grubb A O, et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995; 47: 312–18
- Schardijn G HC, Statius van Eps L W. β2-Microglobulin: its significance in the evaluation of renal function. Kidney Int 1987; 32: 635–41
- Stenman U-H, Huhtala M-L, Koistinen R, Seppala M. Immunochemical demonstration of an ovarian cancer-associated urinary peptide. Int J Cancer 1982; 30: 53–7
- Huhtala M-L, Pesonen K, Kalkkinen N, Stenman U-H. Purification and characterization of a tumor-associated trypsin inhibitor from the urine of a patient with ovarian cancer. J Biol Chem 1982; 257: 13713–6
- Lasson A, Borgström A, Ohlsson K. Elevated pancreatic secretory trypsin inhibitor levels during severe mflammatory disease, renal insufficiency, and after various surgical procedures. Scand J Gastroenterol 1986; 21: 1275–80
- Halila H, Huhtala M-L, Schröder T, Kiviluoto T, Stenman U-H. Pancreatic secretory trypsin inhibitor in pancreatectod patients. Clin Chim Acta 1985; 153: 209–16
- Piantino P, Mosso R, Polloni R, Cerchier A, Gennaretti G, Daziano E. Dosaggio del tumor associated trypsin inhibitor (TATI) in soggetti con malattie gastrointestinali. Minerva Medica 1989; 80: 199–203
- Stenman U-H, Ballesta A, Torre G C. Clinical evaluation of tumor-associated trvusin inhibitor (TATI). Scand J Clin Lab Invest 1991; 51: 5–73, editors, Suppl 207
- Kuopio T, Ekfors T O, Nikkanen V, Mevalainen T J. Acinar cell carcinoma of the pancreas. Report of three cases. APMIS 1995; 103: 69–78
- Pasanen P, Eskelinen M, Partanen K, Pikkarainen P, Penttila I, Ahava E. Tumour-associated trypsin inhibitor in the diagnosis of pancreatic carcinoma. J Cancer Res Clin Oncol 1994; 120: 494–7
- Pasanen P, Eskelinen M, Kulju A, Penttila I, Janatuinen E, Alhava E. Tumour-associated trypsin inhibitor (TATI) in patients with colorectal cancer: a comparison with CEA, CA 50 and CA 242. Scand J Clin Lab Invest 1995; 55: 119–24
- Larbre H, Deltour M, Marechal F, Deltour G. Comparison of a new tumor marker, TATI, to other tumor markers in various cancers. J Tumor Marker Oncol 1990; 5: 305–11
- Meria P, Toubert M E, Cussenot O, Bassi S, Janssen T, Desgrandchamps F, et al. Tumour-associated trypsin inhibitor and renal cell carcinoma. Eur Urol 1995; 27: 223–6
- Banfi G, Murone M, Slaviero G. High concentration of tumor-associated trypsin inhibitor in hemodialyzed patients. Clin Chem 1988; 34: 174–5
- Tramonti G, Ferdeghu M, Donadio C, Annichiarico C, Bianchi R, Bianchi C. Serum concentration of five markers (TATI, TPA, TPS, CYFRA 21—1, SCC) and renal function in man. Advances in management of malignancies, A Carpi, A Sagripanti, B Grassi. Editoriale Bios, Cosenza 1993; 47–9
- Bianchi C, Bonadio M, Donadio C, Tramonti G, Figus S. Measurement of glomerular filtration rate in man using DTPA-99mTc. Nephron 1979; 24: 174–8
- Karlsson F A, Groth T, Sege K, Wibell L. Turnover in humans of β2-microglobulin: the constant chain of HLA-antigens. Eur J Clin Invest 1980; 10: 293–300